（2）In patients receiving ASA who are undergoing elective non-cardiac surgery,we suggest ASA continuation over ASA interruption. In patients receiving ASA therapy whoare undergoing elective surgery and require ASA interruption, we suggeststopping ASA ＜7 days instead of 7 to 10 days before the surgery. Inpatients receiving clopidogrel who are undergoing an elective non-cardiacsurgery, we suggest stopping clopidogrel 5 days instead of 7 to 10 days beforethe surgery, stopping ticagrelor 3 to 5 daysinstead of 7 to 10 days before the surgery, stopping prasugrel 7 days instead of 7to 10 days before the surgery.In patients who require antiplatelet drug interruption we suggest to resume antiplatelet drugs ＜24 hours instead of > 24 hours after the surgery/procedure.不建议在术前停用阿司匹林（颅内手术，脊柱手术除外），如必须停用，可停用＜7天，如服用波立维，只需停用五天，替卡格雷只需停用3-5天，普拉格雷停用7天，并在手术结束后24小时即可恢复使用）
（3）围手术期没必要监测血小板功能
（4）In patients receiving ASA and a P2Y12 inhibitor withcoronary stents placed within the last 6 to 12 weeks who are undergoing anelective surgery, we suggest either continuation of both antiplateletagents or stopping one antiplatelet agent within 7 to 10 days of surgery. within the last 3 to 12 months and are undergoing anelective surgery, we suggest stopping the P2Y12 inhibitor prior tosurgery over continuation of the P2Y12 inhibitor。冠脉支架植入后6-12周患者服用双抗，建议停用其中一种药物7-10天，也可不必停药。冠脉支架植入后3-12月，建议停用P2Y12抑制剂
（5）In patients with coronary stents who require continueddual antiplatelet therapy, we suggest delaying an elective surgery/procedureover not delaying the surgery/procedure. In patients with coronary stents who require interruption of antiplatelet drugs for an elective surgery, we suggest against routine bridging therapy with a glycoprotein IIb/IIIa inhibitor, cangrelor, or LMWH over routine use of bridging therapy（择期手术患者不能停用双抗者，建议延期手术。如必须手术，不建议使用IIb/IIIa受体拮抗剂，低分子肝素等桥接，而使用常规肝素桥接）
|关于我们|业务合作|手机版|新青年麻醉论坛
( 浙ICP备19050841号-1 )
发表于 2024-12-24 14:40:37
QQ好友和群
收藏
淘帖
鲜花
鸡蛋
提升卡
置顶卡
变色卡
